
Promoting Equitable Care through the 4R Oncology® Model
While molecularly targeted therapies based on actionable biomarkers are improving outcomes for patients with lung cancer, access to biomarker testing continues to hinder equitable and comprehensive care for underserved patients. In this episode, CANCER BUZZ TV speaks with Tom Lycan, DO, MHS, assistant professor of Hematology & Oncology at the Wake Forest School of Medicine, about a practical tool that can provide a care plan roadmap for providers and patients to mitigate precision medicine disparities.
"[The 4R Care Sequences pathway] gives an overarching view of what they [patients] are…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.